Wednesday, February 18, 2026 2/18/2026

Covalent regulation of branched chain amino acid metabolism

Award Number: R01DK136749
ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 04/15/2024
PERIOD OF PERFORMANCE END DATE: 02/29/2028

Group Awards By:

View Award Description

Covalent regulation of branched chain amino acid metabolism - PROJECT SUMMARY/ABSTRACT Type 2 diabetes is associated with derangements in a variety of pathways of intermediary metabolism. In addition to the widely-known effects on glucose metabolism, diabetes is also associated with abnormalities in lipid and amino acid metabolism including elevations in branched chain amino acids (BCAA). BCAAs are increased in people with obesity and insulin resistance and high plasma BCAA concentrations are predictive of future development of diabetes. Dietary restriction of BCAAs in rats improves insulin sensitivity and genome- wide association studies in humans have demonstrated that genetic variations in enzymes controlling BCAA metabolism are associated with increased BCAA concentrations and are also linked to the development of insulin resistance. These data suggest that high BCAA concentrations play a causative role in the development of insulin resistance and that strategies that correct accumulation of these bioactive amino acids may have value as therapeutic avenues for treating diabetes. Circulating BCAA concentrations are regulated by dietary intake, rates of protein synthesis and proteolysis, and BCAA catabolism. To be oxidized, BCAAs are first reversibly converted to branched chain keto acids (BCKA) by branched chain aminotransferases. Next, BCKA undergo oxidation that is catalyzed by the BCKA dehydrogenase (BCKDH) enzyme complex in the mitochondrial matrix. BCKDH is regulated by inhibitory phosphorylation and is activated by a protein phosphatase (PPM1K) that removes this covalent modification. Genetic or pharmacologic approaches to reduce BCKDH phosphorylation lead to enhanced BCKA catabolism and improved insulin sensitivity in rodent models of obesity. This application is designed to test the novel hypothesis that PPM1K phosphorylation at a conserved serine residue suppresses the activity of this phosphatase leading to increased BCKDH phosphorylation. Our studies are designed to identify mechanisms by which this phosphorylation is regulated, define the effects of this covalent modification on intrinsic PPM1K activity, and determine the effects of PPM1K phosphorylation on BCAA metabolism in liver of diabetic rodents.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $461,782 )
2025	2025	WASHINGTON UNIVERSITY, THE	1 BROOKINGS DR	SAINT LOUIS	MO	63130	SAINT LOUIS	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	2	2/24/2025	NON-COMPETING CONTINUATION	$415,604
2025	2025	WASHINGTON UNIVERSITY, THE	1 BROOKINGS DR	SAINT LOUIS	MO	63130	SAINT LOUIS	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	001	2	5/14/2025	NON-COMPETING CONTINUATION	$46,178
														Subtotal = $461,782

Issue Date FY: 2024 ( Subtotal = $461,782 )
2024	2024	WASHINGTON UNIVERSITY, THE	ONE BROOKINGS DR	SAINT LOUIS	MO	63110	SAINT LOUIS CITY	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	1	4/9/2024	NEW	$461,782
														Subtotal = $461,782

Grand Total All Awards = $923,564

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Covalent regulation of branched chain amino acid metabolism

Award Number: R01DK136749

ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 04/15/2024

PERIOD OF PERFORMANCE END DATE: 02/29/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer